Funder: European Commission
Due Dates: April 13, 2027: Full application submission deadline (single-stage call HORIZON-HLTH-2027-01-DISEASE-05)
Funding Amounts: €9–11 million per project; total call budget €44.2 million; 5 grants expected; project duration typically 3–5 years.
Summary: Supports research on novel small molecule antivirals targeting specific emerging or re-emerging epidemic-prone viruses, from discovery through early-stage clinical studies.
Key Information: Legal entities established in China are not eligible; clinical studies must use the provided annex template.